13F filerCIK 1536411 ↗
Duquesne Family Office
You are looking at Q2 2018. See the latest, Q3 2026 →
Reported value
$2.07B
+14% on the quarter before
Positions
33
19 new, 8 sold out
Top 10
76.9%
of the value
Est. gain
+$130.9M
on stocks held all quarter
Est. return
+10.9%
on those stocks since Q1 2018
Positions as of Jun 30, 2018, from Duquesne Family Office's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q1 2018. Striped tiles are options.
Largest buys
Since Q1 2018, sized at quarter-end prices.
- Meta~$178.4MNew, 0.0% → 8.6% of the portfolio+918,000 shares
- Gilead Sciences Inc~$85.4MNew, 0.0% → 4.1% of the portfolio+1,205,300 shares
- Microsoft~$54.9MAdded, 12.3% → 14.2% of the portfolio+556,600 shares
- Vaneck Vectors ETF Tr~$44.1MNew, 0.0% → 2.1% of the portfolio+1,680,200 shares
- Marathon Pete Corp~$34.8MNew, 0.0% → 1.7% of the portfolio+496,400 shares
- Splunk Inc~$34.0MNew, 0.0% → 1.6% of the portfolio+342,600 shares
- Autodesk~$33.3MNew, 0.0% → 1.6% of the portfolio+254,300 shares
- Devon Energy Corp New~$32.6MNew, 0.0% → 1.6% of the portfolio+740,700 shares
- Alibaba~$27.3MAdded, 6.7% → 7.2% of the portfolio+146,900 shares
- Activision Blizzard Inc~$25.7MNew, 0.0% → 1.2% of the portfolio+337,200 shares
Largest sells
Since Q1 2018, sized at quarter-end prices.
- Intel~$128.3MSold out, 7.1% → 0.0% of the portfolio−2,462,600 shares
- Nektar Therapeutics~$126.7MSold out, 7.0% → 0.0% of the portfolio−1,192,300 shares
- Micron~$114.1MSold out, 6.3% → 0.0% of the portfolio−2,187,500 shares
- Alphabet~$100.2MCut, 14.9% → 9.3% of the portfolio−88,750 shares
- Jd Com Inc~$72.2MSold out, 4.0% → 0.0% of the portfolio−1,783,000 shares
- Amazon~$26.5MCut, 13.7% → 12.7% of the portfolio−15,600 shares
- Qualcomm~$22.8MSold out, 1.3% → 0.0% of the portfolio−411,000 shares
- Yandex N V~$12.0MSold out, 0.7% → 0.0% of the portfolio−304,000 shares
- Vipshop Hldgs Ltd~$9.5MSold out, 0.5% → 0.0% of the portfolio−572,800 shares
- Sterling Bancorp Del~$9.1MSold out, 0.5% → 0.0% of the portfolio−401,600 shares
Holdings
As of Jun 30, 2018; changes in shares since Mar 31, 2018.
| Holding | Value | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +23% · price +8.0% | 14.2% | $294.5M | +$17.8M | ||||||
| AmazonCOM · shares −9.1% · price +17.4% | 12.7% | $263.9M | +$39.2M | ||||||
| SalesforceCOM · shares 0% · price +17.3% | 11.2% | $232.6M | +$34.3M | ||||||
| AlphabetCAP STK CL A · shares −34% · price +8.9% | 9.3% | $192.4M | +$15.7M | ||||||
| MetaCL A · shares New | 8.6% | $178.4M | — | ||||||
| AlibabaSPONSORED ADS · shares +22% · price +1.1% | 7.2% | $149.2M | +$1.3M | ||||||
| Gilead Sciences IncCOM · shares New | 4.1% | $85.4M | — | ||||||
| WorkdayCL A · shares +14% · price −4.7% | 3.8% | $78.8M | −$3.4M | ||||||
| NetflixCOM · shares 0% · price +32.5% | 3.6% | $74.3M | +$18.2M | ||||||
| Vaneck Vectors ETF TrOIL SVCS ETF · shares New | 2.1% | $44.1M | — | ||||||
| Stamps Com IncCOM NEW · shares −2.2% · price +25.9% | 1.9% | $39.1M | +$8.0M | ||||||
| Marathon Pete CorpCOM · shares New | 1.7% | $34.8M | — | ||||||
| Splunk IncCOM · shares New | 1.6% | $34.0M | — | ||||||
| AutodeskCOM · shares New | 1.6% | $33.3M | — | ||||||
| Devon Energy Corp NewCOM · shares New | 1.6% | $32.6M | — | ||||||
| AdobeCOM · shares 0% · price +12.8% | 1.4% | $29.9M | +$3.4M | ||||||
| Activision Blizzard IncCOM · shares New | 1.2% | $25.7M | — | ||||||
| Tal Ed GroupSPONSORED ADS · shares 0% · price −0.8% | 1.2% | $25.1M | −$197,000 | ||||||
| Select Sector SPDR TrENERGY · shares New | 1.2% | $24.7M | — | ||||||
| Home Depot IncCOM · shares New | 1.2% | $24.7M | — | ||||||
| Ac Immune SaSHS · shares 0% · price −9.9% | 1.1% | $22.3M | −$2.4M | ||||||
| Clovis Oncology IncCOM · shares New | 1.1% | $21.9M | — | ||||||
| Ishares TrNASDAQ BIOTECH · shares New | 0.98% | $20.3M | — | ||||||
| Ctrip Com Intl LtdAMERICAN DEP SHS · shares +38% · price +2.2% | 0.97% | $20.1M | +$308,496 | ||||||
| BlockCL A · shares New | 0.73% | $15.2M | — | ||||||
| Total 33 positions | 100% | $2.07B | +$130.9M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2018 to Q2 2018: 14 stocks held throughout, up $130.9M (+10.9%).
- Amazon+$39.2M+17%
- Salesforce+$34.3M+17%
- Netflix+$18.2M+33%
- Microsoft+$17.8M+8%
- Alphabet+$15.7M+9%
- Tal Ed Group−$197,000−1%
- Pagseguro Digital Ltd Com−$369,791−28%
- Intra Cellular Therapies Inc−$1.0M−16%
- Ac Immune Sa−$2.4M−10%
- Workday−$3.4M−5%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Nov 16, 2026 | $4.47B−14% | SEC ↗ |
| Q2 2026 | Aug 14, 2026 | $5.21B+54% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $3.38B−25% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $4.49B+11% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $4.06B−0% | SEC ↗ |
| Q2 2025 | Aug 15, 2025 | $4.07B+33% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $3.06B−18% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $3.72B+26% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $2.95B+1% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $2.92B−34% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $4.39B+31% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $3.35B+20% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $2.79B−3% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $2.87B+25% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $2.31B+14% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $2.02B+15% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $1.76B+28% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $1.38B−40% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $2.31B−16% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $2.76B−10% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $3.08B−24% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 (amended) | $4.04B−11% | SEC ↗ |
| Q1 2021 | May 17, 2021 (amended) | $4.53B+22% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $3.71B+8% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $3.44B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $3.27B+32% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $2.47B−28% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $3.41B+33% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $2.57B−24% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $3.37B−2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $3.45B+100% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $1.73B−18% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $2.10B+2% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $2.07B+14% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $1.81B−9% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $1.98B−10% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $2.20B+18% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $1.87B+22% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $1.52B+49% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $1.03B−9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $1.13B+30% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $870.7M−35% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $1.34B | SEC ↗ |